Medical Device Mass Tort TV Ad Trends
AdvaMed publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.
Legal
Learn more about our Legal work.
Trendspotting 2022: On the Pulse of Life Sciences
Sidley’s Global Life Sciences group looks at 12 forces driving the life sciences legal and regulatory landscape in 2022, and provides practical tips on a range of topics for life…
Why Law Firm Ownership Matters to Patients and Caregivers
Non-lawyer firm ownership poses particular risks to the medical device industry and the patients & care givers medtech innovators serve every day.
Proposed FCA Amendments Loom Over Medtech Innovation in a Material Way
As medtech innovation outpaces coding and payment systems designed for another era, the threat of meritless False Claims Act cases deters important advancement in technologies patients need.
AdvaMed Files Amicus Brief with California Court of Appeal in Device Labeling Case
The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Senior Vice President, Deputy General Counsel & Director of Litigation regarding this week’s filing of an amicus…
Navigating Patent Risk and Protecting Your Revenue Model in Medical Device Technology Webinar
Learn about how recent developments in patent law affect FTO assessments.
U.S. Health Care Enforcement: Priorities and Key Regulatory Developments Webinar
Join us for our webinar with Sidley Austin to better understand the current health care enforcement landscape with the new administration.
Exposing the Litigation Financing, Advertising and Gaming Techniques That Are Threatening American Health Care
This piece shines light on this mass tort generation machine against medical device manufacturers, explaining how it works and cautioning against the impact it is having on American healthcare.
Global Distributor Compliance Toolkit
AdvaMed and its member companies created a comprehensive toolkit for use by all organizations in the global medical technology supply chain.
AdvaMed Applauds NJ Appellate Division for Reversing Trial Court Order Regarding FDA Evidence Admissibility
AdvaMed issued a statement regarding the decision from the New Jersey Appellate Division’s decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearance…